Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, 2214 Kerr Hall, CB#7573, Chapel Hill, NC, 27599, USA,
Community Ment Health J. 2014 Feb;50(2):185-92. doi: 10.1007/s10597-013-9678-3. Epub 2013 Dec 24.
The objectives of the study were to examine provider-family communication about attention deficit disorder during pediatric asthma visits. Children with asthma, aged 8 through 16 and their parents were recruited at five pediatric practices. All medical visits were audio-taped. There were 296 asthmatic children enrolled into the study and 67 of them also had attention deficit hyperactivity disorder (ADHD). ADHD communication elements suggested by national guidelines were discussed infrequently. Providers were more likely to discuss, educate, and ask one or more questions about ADHD medications if the visit was non-asthma related. Providers included child input into the ADHD treatment regimen during 3% of visits and they included parent input during 4.5% of visits. Only one child and three parents asked questions about ADHD. Providers may neglect essential aspects of good ADHD management and communication in children who have ADHD plus another chronic condition such as asthma. Providers should set appropriate treatment expectations, establish target symptoms, and encourage children and parents to ask questions so mutual decision-making can occur.
本研究旨在探讨儿科哮喘就诊期间医务人员与患儿家庭就注意缺陷障碍（ADHD）进行沟通的情况。研究招募了五家儿科诊所的 8 至 16 岁哮喘患儿及其家长，所有医疗就诊均进行录音。本研究共纳入 296 例哮喘患儿，其中 67 例患儿还患有 ADHD。国家指南建议的 ADHD 沟通要素很少被提及。如果就诊与哮喘无关，医务人员更有可能讨论、教育并询问一个或多个关于 ADHD 药物治疗的问题。在 3%的就诊中，医务人员会让患儿参与 ADHD 治疗方案的制定，而在 4.5%的就诊中，医务人员会让患儿家长参与 ADHD 治疗方案的制定。只有一名患儿和三名患儿家长询问了 ADHD 相关问题。对于患有 ADHD 合并哮喘等其他慢性疾病的儿童，医务人员可能会忽视 ADHD 管理和沟通的重要方面。医务人员应设定适当的治疗预期，确定目标症状，并鼓励患儿及其家长提问，以实现共同决策。
